{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:21:41Z","timestamp":1787325701977,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01801-3","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:01:49Z","timestamp":1734512509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between serum CTRP-5, C3a\/desArg, and complement-C3 levels and hypothyroidism in women with polycystic ovary syndrome"],"prefix":"10.1186","volume":"24","author":[{"given":"Fatima","family":"Abdul-ameer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itlal Jummha AbudlRasool","family":"AlAsadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asieh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-8638","authenticated-orcid":false,"given":"Elham","family":"Bahreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"5","key":"1801_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575\u201392.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1801_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","volume":"28","author":"S Palomba","year":"2017","unstructured":"Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28(3):186\u201398.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1801_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584\u2013618.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1801_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/2230-8210.146860","volume":"19","author":"R Singla","year":"2015","unstructured":"Singla R, Gupta Y, Khemani M, Aggarwal S. Thyroid disorders and polycystic ovary syndrome: an emerging relationship. Indian J Endocrinol Metab. 2015;19(1):25\u20139.","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"1801_CR5","first-page":"e11681","volume":"12","author":"J Singh","year":"2020","unstructured":"Singh J, Wong H, Ahluwalia N, Go RM, Guerrero-Go MA, Metabolic. Hormonal, immunologic, and genetic factors Associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients. Cureus. 2020;12(11):e11681.","journal-title":"Cureus"},{"key":"1801_CR6","doi-asserted-by":"publisher","first-page":"1251866","DOI":"10.3389\/fendo.2023.1251866","volume":"14","author":"S Palomba","year":"2023","unstructured":"Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G. Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature. Front Endocrinol (Lausanne). 2023;14:1251866.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1801_CR7","doi-asserted-by":"publisher","first-page":"1242050","DOI":"10.3389\/fendo.2023.1242050","volume":"14","author":"H Fan","year":"2023","unstructured":"Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1242050.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1801_CR8","doi-asserted-by":"crossref","unstructured":"Kirkegaard S, Uldall Torp NM, Andersen S, Andersen SL. Endometriosis, polycystic ovary syndrome, and the thyroid: a review. Endocr Connect. 2024;13(2).","DOI":"10.1530\/EC-23-0431"},{"key":"1801_CR9","doi-asserted-by":"crossref","unstructured":"Rojhani E, Rahmati M, Firouzi F, Saei Ghare Naz M, Azizi F, Ramezani Tehrani F. Polycystic ovary syndrome, subclinical hypothyroidism, the cut-off value of thyroid stimulating hormone; is there a link? Findings of a Population-based study. Diagnostics (Basel). 2023;13(2).","DOI":"10.3390\/diagnostics13020316"},{"issue":"2","key":"1801_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/2229-5178.202275","volume":"8","author":"MA Keen","year":"2017","unstructured":"Keen MA, Shah IH, Sheikh G. Cutaneous manifestations of polycystic ovary syndrome: a cross-sectional clinical study. Indian Dermatol Online J. 2017;8(2):104\u201310.","journal-title":"Indian Dermatol Online J"},{"issue":"10","key":"1801_CR11","first-page":"1","volume":"15","author":"SS Chuan","year":"2010","unstructured":"Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Therapy Lett. 2010;15(10):1\u20134.","journal-title":"Skin Therapy Lett"},{"issue":"1","key":"1801_CR12","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1038\/s41598-023-37513-2","volume":"13","author":"A Mansour","year":"2023","unstructured":"Mansour A, Mirahmad M, Mohajeri-Tehrani MR, Jamalizadeh M, Hosseinimousa S, Rashidi F, et al. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Sci Rep. 2023;13(1):10269.","journal-title":"Sci Rep"},{"issue":"8","key":"1801_CR13","first-page":"Bc07","volume":"11","author":"K Kar","year":"2017","unstructured":"Kar K, Sinha S. Variations of Adipokines and Insulin Resistance in primary hypothyroidism. J Clin Diagn Res. 2017;11(8):Bc07\u20139.","journal-title":"J Clin Diagn Res"},{"key":"1801_CR14","doi-asserted-by":"crossref","unstructured":"Sch\u00fcler-Toprak S, Ortmann O, Buechler C, Treeck O. The Complex roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis. Biomedicines. 2022;10(10).","DOI":"10.3390\/biomedicines10102503"},{"key":"1801_CR15","doi-asserted-by":"crossref","unstructured":"Bongrani A, Mellouk N, Rame C, Cornuau M, Gu\u00e9rif F, Froment P et al. Ovarian expression of Adipokines in Polycystic Ovary Syndrome: a role for Chemerin, Omentin, and Apelin in follicular growth arrest and ovulatory dysfunction? Int J Mol Sci. 2019;20(15).","DOI":"10.3390\/ijms20153778"},{"issue":"4","key":"1801_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/ol.2021.12984","volume":"22","author":"M Kong","year":"2021","unstructured":"Kong M, Gao Y, Guo X, Xie Y, Yu Y. Role of the CTRP family in tumor development and progression. Oncol Lett. 2021;22(4):723.","journal-title":"Oncol Lett"},{"key":"1801_CR17","doi-asserted-by":"publisher","first-page":"653293","DOI":"10.3389\/fmed.2021.653293","volume":"8","author":"J Han","year":"2021","unstructured":"Han J, Zhang X, Complement Component C. A novel biomarker participating in the pathogenesis of non-alcoholic fatty liver disease. Front Med (Lausanne). 2021;8:653293.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1801_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","volume":"274","author":"D Ricklin","year":"2016","unstructured":"Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. Complement component C3 - the Swiss Army Knife of innate immunity and host defense. Immunol Rev. 2016;274(1):33\u201358.","journal-title":"Immunol Rev"},{"issue":"4","key":"1801_CR19","doi-asserted-by":"publisher","first-page":"e0122026","DOI":"10.1371\/journal.pone.0122026","volume":"10","author":"Q Jia","year":"2015","unstructured":"Jia Q, Li C, Xia Y, Zhang Q, Wu H, Du H, et al. Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study. PLoS ONE. 2015;10(4):e0122026.","journal-title":"PLoS ONE"},{"key":"1801_CR20","doi-asserted-by":"publisher","first-page":"1218880","DOI":"10.3389\/fendo.2023.1218880","volume":"14","author":"YK Chen","year":"2023","unstructured":"Chen YK, Liu TT, Teia FKF, Xie MZ. Exploring the underlying mechanisms of obesity and diabetes and the potential of traditional Chinese medicine: an overview of the literature. Front Endocrinol (Lausanne). 2023;14:1218880.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1801_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/0022-4804(89)90162-5","volume":"46","author":"MJ Walsh","year":"1989","unstructured":"Walsh MJ, Sniderman AD, Cianflone K, Vu H, Rodriguez MA, Forse RA. The effect of ASP on the adipocyte of the morbidly obese. J Surg Res. 1989;46(5):470\u20133.","journal-title":"J Surg Res"},{"key":"1801_CR22","doi-asserted-by":"publisher","first-page":"1071922","DOI":"10.3389\/fendo.2022.1071922","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Song K, Luo W. Association between circulating resistin levels and thyroid dysfunction: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:1071922.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-7075-3-13","volume":"3","author":"H Yu","year":"2006","unstructured":"Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, et al. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond). 2006;3:13.","journal-title":"Nutr Metab (Lond)"},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1801_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1253\/jcj.50.1191","volume":"50","author":"Y Hata","year":"1986","unstructured":"Hata Y, Nakajima K. Application of Friedewald\u2019s LDL-cholesterol estimation formula to serum lipids in the Japanese population. Jpn Circ J. 1986;50(12):1191\u2013200.","journal-title":"Jpn Circ J"},{"issue":"2","key":"1801_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.fertnstert.2012.10.006","volume":"99","author":"CL Benetti-Pinto","year":"2013","unstructured":"Benetti-Pinto CL, Piccolo VRSB, Garmes HM, Juliato CRT. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters. Fertil Steril. 2013;99(2):588\u201392.","journal-title":"Fertil Steril"},{"issue":"2","key":"1801_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","volume":"169","author":"S Garelli","year":"2013","unstructured":"Garelli S, Masiero S, Plebani M, Chen S, Furmaniak J, Armanini D, et al. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reproductive Biology. 2013;169(2):248\u201351.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"1801_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00404-011-2040-5","volume":"285","author":"M Kachuei","year":"2012","unstructured":"Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;285:853\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1801_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/09513590.2014.958990","volume":"31","author":"JSM Novais","year":"2015","unstructured":"Novais JSM, Benetti-Pinto CL, Garmes HM, Menezes Jales R, Juliato CRT. Polycystic ovary syndrome and chronic autoimmune thyroiditis. Gynecol Endocrinol. 2015;31(1):48\u201351.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1801_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4274\/jtgga.galenos.2018.2018.0027","volume":"20","author":"M \u00c7alan","year":"2019","unstructured":"\u00c7alan M, Alan M, Alarslan P, Kocaba\u015f G\u00dc, Bozkaya G, Acara A\u00c7, et al. Association of decreased C1q\/tumor necrosis factorrelated protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome. J Turkish German Gynecol Association. 2019;20(2):89.","journal-title":"J Turkish German Gynecol Association"},{"issue":"2","key":"1801_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21608\/ejhm.2020.70969","volume":"78","author":"TAE-S Ibrahim","year":"2020","unstructured":"Ibrahim TAE-S, Ali AE-S, Radwan ME-H. Lipid profile in women with polycystic ovary syndrome. Egypt J Hosp Med. 2020;78(2):272\u20137.","journal-title":"Egypt J Hosp Med"},{"key":"1801_CR32","doi-asserted-by":"publisher","first-page":"7201473","DOI":"10.1155\/2018\/7201473","volume":"2018","author":"F Jiang","year":"2018","unstructured":"Jiang F, Yang M, Zhao X, Liu R, Yang G, Liu D, et al. C1q\/TNF-Related Protein5 (CTRP5) as a Biomarker to predict metabolic syndrome and each of its components. Int J Endocrinol. 2018;2018:7201473.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1801_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13098-021-00631-w","volume":"13","author":"Z Majidi","year":"2021","unstructured":"Majidi Z, Emamgholipour S, Omidifar A, Rahmani Fard S, Poustchi H, Shanaki M. The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study. Diabetol Metab Syndr. 2021;13(1):14.","journal-title":"Diabetol Metab Syndr"},{"key":"1801_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13098-015-0099-z","volume":"7","author":"S Emamgholipour","year":"2015","unstructured":"Emamgholipour S, Moradi N, Beigy M, Shabani P, Fadaei R, Poustchi H, et al. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. Diabetol Metab Syndr. 2015;7:108.","journal-title":"Diabetol Metab Syndr"},{"key":"1801_CR35","doi-asserted-by":"crossref","unstructured":"Jiang F, Yang M, Zhao X, Liu R, Yang G, Liu D et al. C1q\/TNF-related protein5 (CTRP5) as a biomarker to predict metabolic syndrome and each of its components. International journal of endocrinology. 2018;2018.","DOI":"10.1155\/2018\/7201473"},{"issue":"2","key":"1801_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/BJ20081240","volume":"416","author":"GW Wong","year":"2008","unstructured":"Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. Molecular, biochemical and functional characterizations of C1q\/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-\u03b3 agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 2008;416(2):161\u201377.","journal-title":"Biochem J"},{"issue":"41","key":"1801_CR37","doi-asserted-by":"publisher","first-page":"27780","DOI":"10.1074\/jbc.M109.005611","volume":"284","author":"S-Y Park","year":"2009","unstructured":"Park S-Y, Choi JH, Ryu HS, Pak YK, Park KS, Lee HK, et al. C1q tumor necrosis factor \u03b1-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. J Biol Chem. 2009;284(41):27780\u20139.","journal-title":"J Biol Chem"},{"key":"1801_CR38","doi-asserted-by":"crossref","unstructured":"Wong GW, Wang J, Hug C, Tsao T-S, Lodish HF. A family of Acrp30\/adiponectin structural and functional paralogs. Proceedings of the National Academy of Sciences. 2004;101(28):10302-7.","DOI":"10.1073\/pnas.0403760101"},{"key":"1801_CR39","doi-asserted-by":"crossref","unstructured":"Schmid A, Kopp A, Aslanidis C, Wabitsch M, M\u00fcller M, Sch\u00e4ffler A. Regulation and function of C1Q\/TNF-related protein-5 (CTRP-5) in the context of adipocyte biology. Exp Clin Endocrinol Diabetes. 2013;121(5):310\u20137.","DOI":"10.1055\/s-0032-1333299"},{"issue":"3","key":"1801_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bbrc.2014.08.145","volume":"452","author":"W-M Yang","year":"2014","unstructured":"Yang W-M, Lee W. CTRP5 ameliorates palmitate-induced apoptosis and insulin resistance through activation of AMPK and fatty acid oxidation. Biochem Biophys Res Commun. 2014;452(3):715\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"1801_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13044-019-0070-4","volume":"12","author":"M Karkhaneh","year":"2019","unstructured":"Karkhaneh M, Qorbani M, Ataie-Jafari A, Mohajeri-Tehrani MR, Asayesh H, Hosseini S. Association of thyroid hormones with resting energy expenditure and complement C3 in normal weight high body fat women. Thyroid Res. 2019;12:1\u20136.","journal-title":"Thyroid Res"},{"issue":"3","key":"1801_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/153537020623100301","volume":"231","author":"JR Klein","year":"2006","unstructured":"Klein JR. The immune system as a regulator of thyroid hormone activity. Experimental Biology Med. 2006;231(3):229\u201336.","journal-title":"Experimental Biology Med"},{"issue":"1","key":"1801_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.fertnstert.2007.11.031","volume":"91","author":"Y Wu","year":"2009","unstructured":"Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril. 2009;91(1):213\u20139.","journal-title":"Fertil Steril"},{"key":"1801_CR44","doi-asserted-by":"crossref","unstructured":"Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP, Hypothyroidism (Primer), editors. Nature Reviews: Disease Primers. 2022;8(1).","DOI":"10.1038\/s41572-022-00357-7"},{"issue":"1","key":"1801_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/2230-8210.146860","volume":"19","author":"R Singla","year":"2015","unstructured":"Singla R, Gupta Y, Khemani M, Aggarwal S. Thyroid disorders and polycystic ovary syndrome: an emerging relationship. Indian J Endocrinol Metabol. 2015;19(1):25.","journal-title":"Indian J Endocrinol Metabol"},{"issue":"2","key":"1801_CR46","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/2230-8210.109714","volume":"17","author":"U Sinha","year":"2013","unstructured":"Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metabol. 2013;17(2):304.","journal-title":"Indian J Endocrinol Metabol"},{"key":"1801_CR47","doi-asserted-by":"crossref","unstructured":"Delitala AP, Scuteri A, Fiorillo E, Lakatta EG, Schlessinger D, Cucca F. Role of Adipokines in the association between thyroid hormone and components of the metabolic syndrome. J Clin Med. 2019;8(6).","DOI":"10.3390\/jcm8060764"},{"key":"1801_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cyto.2018.08.027","volume":"111","author":"AP Delitala","year":"2018","unstructured":"Delitala AP, Steri M, Fiorillo E, Marongiu M, Lakatta EG, Schlessinger D, et al. Adipocytokine correlations with thyroid function and autoimmunity in euthyroid sardinians. Cytokine. 2018;111:189\u201393.","journal-title":"Cytokine"},{"key":"1801_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-3-13","volume":"3","author":"H Yu","year":"2006","unstructured":"Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, et al. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metabolism. 2006;3:1\u20138.","journal-title":"Nutr Metabolism"},{"key":"1801_CR50","doi-asserted-by":"crossref","unstructured":"Nath CK, Barman B, Das A, Rajkhowa P, Baruah P, Baruah M, Baruah A. Prolactin and thyroid stimulating hormone affecting the pattern of LH\/FSH secretion in patients with polycystic ovary syndrome: a hospital-based study from North East India. J Family Med Prim Care. 2019;8(1):256\u201360.","DOI":"10.4103\/jfmpc.jfmpc_281_18"},{"key":"1801_CR51","first-page":"11","volume":"2","author":"RK Padalkar","year":"2017","unstructured":"Padalkar RK, Patil SM, Andure DV, Bhagat SS, Raut AM. Study of hormone and lipid profile in polycystic ovarian syndrome women between the age 18 to 30 years. J Pract Biochem Biophys. 2017;2:11\u20135.","journal-title":"J Pract Biochem Biophys"},{"issue":"2","key":"1801_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1530\/EJE-16-0548","volume":"176","author":"S Nazarpour","year":"2017","unstructured":"Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017;176(2):253\u201365.","journal-title":"Eur J Endocrinol"},{"key":"1801_CR53","first-page":"44","volume":"1","author":"SM Ghoraishian","year":"2006","unstructured":"Ghoraishian SM, Moghaddam SHH, Afkhami M. Relationship between anti-thyroid peroxidase antibody and thyroid function tests. World J Med Sci. 2006;1:44\u20137.","journal-title":"World J Med Sci"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01801-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:09:46Z","timestamp":1734520186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01801-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures conducted in the study involving human participants adhered to the ethical standards set forth by the institutional and\/or national research committee and were aligned with the principles outlined in the 1964 Helsinki Declaration. The Ethics Commission at the Iran University of Medical Sciences assessed the project\u2019s adherence to the \u201cHelsinki Laws\u201d and approved the study (Ethical Code: IR.IUMS.REC.1402.669). Upon selecting a suitable participant following a thorough examination by a physician, she was invited to participate in the project. The project\u2019s objectives, procedures, including blood sampling, and the assurance of data confidentiality were explained to her, along with the option to withdraw from the study at any point of her choosing. Informed consent was obtained from all individual participants who were part of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}